Beyond neurodegenerative diseases: α-synuclein in erythropoiesis

References

• Maroteaux L, Campanelli JT, Scheller RH. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 1988;8(8):2804–2815.
   PubMed Web of Science ®Google Scholar
• Araki K, Yagi N, Aoyama K, et al. Parkinson’s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein. Proc Natl Acad Sci USA. 2019;116(36):17963–17969.
   PubMed Web of Science ®Google Scholar
• Emelyanov A, Kulabukhova D, Garaeva L, et al. SNCA variants and alpha-synuclein level in CD45 + blood cells in Parkinson’s disease. J Neurol Sci. 2018;395:135–140.
   PubMed Web of Science ®Google Scholar
• Gelpi E, Navarro-Otano J, Tolosa E, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Movement Disord. 2014;29(8):1010–1018.
   PubMed Web of Science ®Google Scholar
• Khoshi A, Goodarzi G, Mohammadi R, et al. Reducing effect of insulin resistance on alpha-synuclein gene expression in skeletal muscle. Diabetol Metab Syndr. 2019;11:99.
   PubMed Web of Science ®Google Scholar
• Lee BR, Kamitani T. Improved immunodetection of endogenous alpha-synuclein. PLoS One. 2011;6(8):e23939.
   PubMed Web of Science ®Google Scholar
• Baksi S, Tripathi AK, Singh N. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: implications for visual manifestations of Parkinson’s disease. Free Radical Bio Med. 2016;97:292–306.
   PubMed Web of Science ®Google Scholar
• Berger-Sieczkowski E, Lutz MI, Auff E, et al. Gaucher cells are not associated with alpha-synuclein neuropathology in infants. Clin Neuropathol. 2016;35(3):122–128.
   PubMed Web of Science ®Google Scholar
• Barkovits K, Kruse N, Linden A, et al. Blood contamination in CSF and its impact on quantitative analysis of alpha-synuclein. Cells (Basel, Switzerland). 2020;9(2):370.
   Google Scholar
• Nakai M, Fujita M, Waragai M, et al. Expression of alpha-synuclein, a presynaptic protein implicated in Parkinson’s disease, in erythropoietic lineage. Biochem Biophys Res Commun. 2007;358(1):104–110.
   PubMed Web of Science ®Google Scholar
• Abd-Elhadi S, Basora M, Vilas D, et al. Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA. Anal Bioanal Chem. 2016;408(27):7669–7677.
   PubMed Web of Science ®Google Scholar
• Miller DW, Hague SM, Clarimon J, et al. Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication. Neurology. 2004;62(10):1835–1838.
   PubMed Web of Science ®Google Scholar
• Mizuta I, Tsunoda T, Satake W, et al. Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson’s disease. Hum Genet. 2008;124(1):89–94.
   PubMed Web of Science ®Google Scholar
• Araki K, Sugawara K, Hayakawa EH, et al. The localization of alpha-synuclein in the process of differentiation of human erythroid cells. Int J Hematol. 2018;108(2):130–138.
   PubMed Web of Science ®Google Scholar
• Renella R, Schlehe JS, Selkoe DJ, et al. Genetic deletion of the GATA1-regulated protein alpha-synuclein reduces oxidative stress and nitric oxide synthase levels in mature erythrocytes. Am J Hematol. 2014;89(10):974–977.
   PubMed Web of Science ®Google Scholar
• Peelaerts W, Bousset L, Van der Perren A, et al. Alpha-synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015;522(7556):340–344.
   PubMed Web of Science ®Google Scholar
• Matsumoto J, Stewart T, Sheng L, et al. Transmission of alpha-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease? Acta Neuropathol Commun. 2017;5(1):71.
   PubMedGoogle Scholar
• Sui Y, Bullock KM, Erickson MA, et al. Alpha synuclein is transported into and out of the brain by the blood–brain barrier. Peptides. 2014;62:197–202.
   PubMed Web of Science ®Google Scholar
• Alegre-Abarrategui J, Brimblecombe KR, Roberts RF, et al. Selective vulnerability in α-synucleinopathies. Acta Neuropathol. 2019;138(5):681–704.
   PubMed Web of Science ®Google Scholar
• Ray B, Mahalakshmi AM, Tuladhar S, et al. “Janus-Faced” α-synuclein: role in Parkinson’s disease. Front Cell Dev Biol. 2021;9:673395.
   PubMedGoogle Scholar
• Bougeaa A. Synuclein in neurodegeneration. Adv Clin Chem. 2021;103:97–134.
   PubMed Web of Science ®Google Scholar
• Fuchs J, Tichopad A, Golub Y, et al. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. FASEB J. 2008;22(5):1327–1334.
   PubMed Web of Science ®Google Scholar
• Kessler JC, Rochet JC, Lansbury PJ. The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation. Biochemistry-US. 2003;42(3):672–678.
   PubMed Web of Science ®Google Scholar
• Lashuel HA, Overk CR, Oueslati A, et al. The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2013;14(1):38–48.
   PubMed Web of Science ®Google Scholar
• Theillet F, Binolfi A, Bekei B, et al. Structural disorder of monomeric α-synuclein persists in mammalian cells. Nature. 2016;530(7588):45–50.
   PubMed Web of Science ®Google Scholar
• Abd-Elhadi S, Honig A, Simhi-Haham D, et al. Total and proteinase K-resistant alpha-synuclein levels in erythrocytes, determined by their ability to bind phospholipids, associate with Parkinson’s disease. Sci Rep. 2015;5:11120.
   PubMed Web of Science ®Google Scholar
• Okochi M, Walter J, Koyama A, et al. Constitutive phosphorylation of the Parkinson’s disease associated alpha-synuclein. J Biol Chem. 2000;275(1):390–397.
   PubMed Web of Science ®Google Scholar
• Stephens AD, Zacharopoulou M, Kaminski Schierle GS. The cellular environment affects monomeric α-synuclein structure. Trends Biochem Sci. 2019;44(5):453–466.
   PubMed Web of Science ®Google Scholar
• Cascella R, Bigi A, Cremades N, et al. Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies. Cell Mol Life Sci. 2022;79(3):174.
   PubMed Web of Science ®Google Scholar
• Bartels T, Choi JG, Selkoe DJ. α-synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature. 2011;477(7362):107–110.
   PubMed Web of Science ®Google Scholar
• Wang W, Perovic I, Chittuluru J, et al. A soluble α-synuclein construct forms a dynamic tetramer. Proc Natl Acad Sci USA. 2011;108(43):17797–17802.
   PubMed Web of Science ®Google Scholar
• Fauvet B, Mbefo MK, Fares MB, et al. α-synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J Biol Chem. 2012;287(19):15345–15364.
   PubMed Web of Science ®Google Scholar
• Burré J, Vivona S, Diao J, et al. Properties of native brain α-synuclein. Nature (London). 2013;498(7453):E4–E6.
   PubMed Web of Science ®Google Scholar
• Araki K, Yagi N, Nakatani R, et al. A small-angle X-ray scattering study of alpha-synuclein from human red blood cells. Sci Rep. 2016;6:30473.
   PubMed Web of Science ®Google Scholar
• Barbour R, Kling K, Anderson JP, et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 2008;5(2):55–59.
   PubMed Web of Science ®Google Scholar
• Scherzer CR, Grass JA, Liao Z, et al. GATA transcription factors directly regulate the Parkinson’s disease-linked gene α-synuclein. Proc Natl Acad Sci USA. 2008;105(31):10907–10912.
   PubMed Web of Science ®Google Scholar
• Maitta RW, Wolgast LR, Wang Q, et al. Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia. Am J Hematol. 2011;86(2):230–234.
   PubMed Web of Science ®Google Scholar
• Daniele S, Costa B, Pietrobono D, et al. Epigenetic modifications of the alpha-synuclein gene and relative protein content are affected by ageing and physical exercise in blood from healthy subjects. Oxid Med Cell Longev. 2018;2018:3740345.
   PubMed Web of Science ®Google Scholar
• Jelkmann W. Regulation of erythropoietin production. J Physiol. 2011;589(6):1251–1258.
   PubMed Web of Science ®Google Scholar
• Yu M, Riva L, Xie H, et al. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol Cell. 2009;36(4):682–695.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Wu W, Kumar SA, et al. Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression. Genome Res. 2009;19(12):2172–2184.
   PubMed Web of Science ®Google Scholar
• Moraitou M, Dermentzaki G, Dimitriou E, et al. Alpha-synuclein dimerization in erythrocytes of Gaucher disease patients: correlation with lipid abnormalities and oxidative stress. Neurosci Lett. 2016;613:1–5.
   PubMed Web of Science ®Google Scholar
• Witt SN. Molecular chaperones, alpha-synuclein, and neurodegeneration. Mol Neurobiol. 2013;47(2):552–560.
   PubMed Web of Science ®Google Scholar
• Abeliovich A, Schmitz Y, Fariñas I, et al. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25(1):239–252.
   PubMed Web of Science ®Google Scholar
• Xiao W, Shameli A, Harding CV, et al. Late stages of hematopoiesis and B cell lymphopoiesis are regulated by α-synuclein, a key player in Parkinson’s disease. Immunobiology. 2014;219(11):836–844.
   PubMed Web of Science ®Google Scholar
• Tashkandi H, Shameli A, Harding CV, et al. Ultrastructural changes in peripheral blood leukocytes in alpha-synuclein knockout mice. Blood Cells Mol Dis. 2018;73:33–37.
   PubMed Web of Science ®Google Scholar
• Scott C, Arora G, Dickson K, et al. Iron chelation in local infection. Molecules. 2021;26(1):189.
   PubMed Web of Science ®Google Scholar
• Ajioka RS, Phillips JD, Kushner JP. Biosynthesis of heme in mammals. Biochim Biophys Acta. 2006;1763(7):723–736.
   PubMed Web of Science ®Google Scholar
• Yang W, Li X, Li X, et al. Hemoglobin-α-synuclein complex exhibited age-dependent alterations in the human striatum and peripheral RBCs. Neurosci Lett. 2020;736:135274.
   PubMed Web of Science ®Google Scholar
• Brown DR. α-synuclein as a ferrireductase. Biochem Soc T. 2013;41(6):1513–1517.
   PubMedGoogle Scholar
• Santiago JA, Potashkin JA. Blood transcriptomic meta-analysis identifies dysregulation of hemoglobin and iron metabolism in Parkinson’s disease. Front Aging Neurosci. 2017;9:73.
   PubMed Web of Science ®Google Scholar
• Pei Y, Maitta RW. Alpha synuclein in hematopoiesis and immunity. Heliyon. 2019;5(10):e2590.
   Web of Science ®Google Scholar
• Shin EC, Cho SE, Lee DK, et al. Expression patterns of alpha-synuclein in human hematopoietic cells and in drosophila at different developmental stages. Mol Cells. 2000;10(1):65–70.
   PubMed Web of Science ®Google Scholar
• Shameli A, Xiao W, Zheng Y, et al. A critical role for alpha-synuclein in development and function of T lymphocytes. Immunobiology. 2016;221(2):333–340.
   PubMed Web of Science ®Google Scholar
• Chiang SC, Theorell J, Entesarian M, et al. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. Blood. 2013;121(8):1345–1356.
   PubMed Web of Science ®Google Scholar
• Gardai SJ, Mao W, Schüle B, et al. Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson’s disease. PLoS One. 2013;8(8):e71634.
   PubMed Web of Science ®Google Scholar
• Park SM, Jung HY, Kim HO, et al. Evidence that alpha-synuclein functions as a negative regulator of Ca++-dependent alpha-granule release from human platelets. Blood. 2002;100(7):2506–2514.
   PubMed Web of Science ®Google Scholar
• Stefaniuk CM, Schlegelmilch J, Meyerson HJ, et al. Initial assessment of α-synuclein structure in platelets. J Thromb Thrombolysis. 2021. doi:10.1007/s11239-021-02607-z.
   PubMed Web of Science ®Google Scholar
• Stefaniuk CM, Hong H, Harding CV, et al. α-synuclein concentration increases over time in plasma supernatant of single donor platelets. Eur J Haematol. 2018;101(5):630–634.
   Web of Science ®Google Scholar
• Savica R, Grossardt BR, Carlin JM, et al. Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology. 2009;73(17):1381–1387.
   PubMed Web of Science ®Google Scholar
• Hong CT, Huang YH, Liu HY, et al. Newly diagnosed anemia increases risk of Parkinson’s disease: a population-based cohort study. Sci Rep-UK. 2016;6:29651.
   PubMed Web of Science ®Google Scholar
• Pretorius E, Swanepoel AC, Buys AV, et al. Eryptosis as a marker of Parkinson’s disease. Aging (Albany, NY.). 2014;6(10):788–819.
   PubMedGoogle Scholar
• Liu G, Tian C, Gao L, et al. Alpha-synuclein in erythrocyte membrane of patients with multiple system atrophy: a pilot study. Parkinsonism Reatl D. 2019;60:105–110.
   PubMed Web of Science ®Google Scholar
• Tofaris GK, Buckley NJ. Convergent molecular defects underpin diverse neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2018;89(9):962–969.
   PubMed Web of Science ®Google Scholar
• Wang X, Yu S, Li F, et al. Detection of alpha-synuclein oligomers in red blood cells as a potential biomarker of Parkinson’s disease. Neurosci Lett. 2015;599:115–119.
   PubMed Web of Science ®Google Scholar
• Papagiannakis N, Koros C, Stamelou M, et al. Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson’s disease. Neurosci Lett. 2018;672:145–149.
   PubMed Web of Science ®Google Scholar
• Tian C, Liu G, Gao L, et al. Erythrocytic α-synuclein as a potential biomarker for Parkinson’s disease. Transl Neurodegener. 2019;8:15.
   PubMed Web of Science ®Google Scholar
• Foulds PG, Mitchell JD, Parker A, et al. Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson’s disease. FASEB J. 2011;25(12):4127–4137.
   PubMed Web of Science ®Google Scholar
• Daniele S, Frosini D, Pietrobono D, et al. α-synuclein heterocomplexes with beta-amyloid are increased in red blood cells of Parkinson’s disease patients and correlate with disease severity. Front Mol Neurosci. 2018;11:53.
   PubMed Web of Science ®Google Scholar
• Klatt S, Roberts A, Lothian A, et al. Optimizing red blood cell protein extraction for biomarker quantitation with mass spectrometry. Anal Bioanal Chem. 2020;412(8):1879–1892.
   PubMed Web of Science ®Google Scholar